13.3 million Indonesians fully vaccinated against COVID-19

13.3 million Indonesians fully vaccinated against COVID-19

Jakarta (ANTARA) - As many as 13,329,738 Indonesians have received the full dose of the COVID-19 vaccine under the national vaccination program, which is targeting to build herd immunity against the virus, the COVID-19 Task Force has reported.

A total of 147,704 people received the second dose of the COVID-19 vaccine on Tuesday.

Meanwhile, 884,876 people received their first vaccine dose on Tuesday, which brought the total tally of recipients of the first dose to 28,304,774.

The government has intensified the vaccination program and is targeting to administer at least one million doses daily to speed up the realization of herd immunity.

Under the first phase of the vaccination program, the government is aiming to inoculate 40,349,049 people against COVID-19 out of the 181.5 million recipients targeted by the national immunization program overall.

Earlier, spokesperson for COVID-19 vaccinations at the Ministry of Health, Siti Nadia Tarmizi, had said that the vaccine dosage for the 12-17 age group will be the same as for those aged 18 years and above.

"Regarding the injection, it's the same dose at 1/2 ml for the age group 18 years and over," she informed.

President Joko Widodo has announced the grant of an emergency-use permit, or EUA, for Sinovac's Coronavac vaccine, produced by PT Bio Farma, for the 12-17 age group, she said.

"This emergency approval provides additional targets to protect children," she remarked.

Concerning news reports about the use of the Pfizer vaccine from the US, she said that currently, the BPOM has only issued an emergency-use permit for Sinovac's Coronavac, produced by Bio Farma, so far.

"Pfizer is part of vaccines that we have planned to procure to meet the needs for 181.5 million targets in Indonesia," she added. (INE)

Related news: President urges local governments to double vaccination target
Related news: COVID vaccinations to begin soon for children aged 12-17: President


EDITED BY INE

Comments